Chronic itch can be extremely devastating
and, in many cases, difficult
to treat. One challenge in treating itch disorders is the limited
understanding of the multitude of chemical players involved in the
communication of itch sensation from the peripheral to the central
nervous system. Neuropeptides are intercellular signaling molecules
that are known to be involved in the transmission of itch signals
from primary afferent neurons, which detect itch in the skin, to higher-order
circuits in the spinal cord and brain. To investigate the role of
neuropeptides in transmitting itch signals, we generated two mouse
models of chronic itchAcetone–Ether–Water (AEW,
dry skin) and calcipotriol (MC903, atopic dermatitis). For peptide
identification and quantitation, we analyzed the peptide content of
dorsal root ganglia (DRG) and dorsal horn (DH) tissues from chronically
itchy mice using liquid chromatography coupled to tandem mass spectrometry.
De novo-assisted database searching facilitated the identification
and quantitation of 335 peptides for DH MC903, 318 for DH AEW, 266
for DRG MC903, and 271 for DRG AEW. Of these quantifiable peptides,
we detected 30 that were differentially regulated in the tested models,
after accounting for multiple testing correction (q ≤ 0.1). These include several peptide candidates derived
from neuropeptide precursors, such as proSAAS, protachykinin-1, proenkephalin,
and calcitonin gene-related peptide, some of them previously linked
to itch. The peptides identified in this study may help elucidate
our understanding about these debilitating disorders. Data are available
via ProteomeXchange with identifier PXD015949.